The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases

Abstract

Autophagy, originally found in liver experiments, is a cellular process that degrades damaged organelle or protein aggregation. This process frees cells from various stress states is a cell survival mechanism under stress stimulation. It is now known that dysregulation of autophagy can cause many liver diseases. Therefore, how to properly regulate autophagy is the key to the treatment of liver injury. mechanistic target of rapamycin (mTOR)is the core hub regulating autophagy, which is subject to different upstream signaling pathways to regulate autophagy. This review summarizes three upstream pathways of mTOR: the phosphoinositide 3-kinase (PI3K)/protein kinase (AKT) signaling pathway, the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway, and the rat sarcoma (Ras)/rapidly accelerated fibrosarcoma (Raf)/mitogen-extracellular activated protein kinase kinase (MEK)/ extracellular-signal-regulated kinase (ERK) signaling pathway, specifically explored their role in liver fibrosis, hepatitis B, non-alcoholic fatty liver, liver cancer, hepatic ischemia reperfusion and other liver diseases through the regulation of mTOR-mediated autophagy. Moreover, we also analyzed the crosstalk between these three pathways, aiming to find new targets for the treatment of human liver disease based on autophagy.

Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway

“…Mammalian mTOR is a component of mechanistic target of rapamycin c1 (mTORc1). When it is sensitive to rapamycin, it regulates intracellular nutrition, growth factors, pressure and other signals and activates PRAS40, a protein that binds to mTORc1, causing PRAS40 to separate from mTORc1 (22). When it is not sensitive to rapamycin, it controls cell proliferation and survival.…”

Protective effects of PAMAM dendrimers against ANIT-induced cholestatic liver injury in mice

“…Latest Studies manifested that it can promote liver fibrosis by activating PI3K/AKT/mTOR signaling. [47,48] However,the effect and relationship of PPAR-γ and PI3K/AKT/mTOR signaling pathway in Cholestatic Liver disease is not certain. Through our research we found cholestatic liver can significantly elevate the P-Akt P-mTOR protein expression.…”

Moving Forward: Gene Therapy for Intervertebral Disc Degeneration

“…7 The mTOR plays a negative role in autophagy by regulating autophagy-related proteins and lysosome biosynthesis. 8 The author proposes selective interference of mTORC1 (mTOR complex 1)/RAPTOR (regulatoryassociated protein of mTOR) to protect disc cells from inflammation-induced apoptosis, senescence, and prevent ECM catabolism.…”